Aurinia Pharmaceuticals Inc (AUPH) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Aurinia Pharmaceuticals Inc   (NASDAQ: AUPH)
 

Aurinia Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Aurinia Pharmaceuticals Inc 's inventory turnover ratio, the ratio that measures Aurinia Pharmaceuticals Inc 's ability to manage its supply chain, sequentially decreased to 1.29 in the third quarter 2026, which does not come as a surprise, as the Aurinia Pharmaceuticals Inc continue to experience headwinds, which also impact its supply chain. Aurinia Pharmaceuticals Inc 's average inventory processing period in the Sep 30 2026 quarter, has increased to 283 days, from 156 days, in the Jun 30 2026 quarter.

Within Healthcare sector 285 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2026, to 288, from total ranking in the second quarter 2026 at 1754.

AUPH Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Aurinia Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AUPH Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth 3057.26 % 1658.9 % 17.84 % -58.03 % -
Y / Y Cost of Sales Growth 1.58 % -7.87 % -24.13 % 58.48 % 35.49 %
Inventory Turnover Ratio (TTM) 1.29 2.34 14.12 16.31 13.79
AUPH's Total Ranking # 288 # 1754 # 1236 # 1183 #
Average inventory processing period 283 156 26 22 26
Seq. Inventory Growth -3.15 % 941.79 % 1043.54 % -72.64 % -46.05 %
Seq. Cost of Sales Growth 26.71 % 0.77 % -26.07 % 7.61 % 14.93 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 80
Healthcare Sector # 286
Overall Market # 288

Inventory Turnover Ratio Statistics
High Average Low
42.97 6.28 0.04
(Jun 30 2024)   (Sep 30 2021)



AUPH Company Profile >> Back to AUPH Efficiency Comparisons >> Compare AUPH Inventory Turnover Ratio to its Competitors

Financial Statements
Aurinia Pharmaceuticals Inc 's Inventories $ 44 Millions Visit AUPH's Balance sheet
Aurinia Pharmaceuticals Inc 's Cost of Revenues TTM $ 30 Millions Visit AUPH's Income Statement
What are AUPH's Sales? Visit AUPH's Sales by Segment

Other Inventory Turnover Ratios
Aurinia Pharmaceuticals Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
AUPH's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for AUPH's Competitors
Inventory Turnover Ratio for AUPH's Suppliers
Inventory Turnover Ratio for AUPH's Customers

You may also want to know
AUPH's Sales Growth Rates AUPH's Pe Price to earnings ratio AUPH's Receivables Turnover Ratio AUPH's Stock Quote
AUPH's Net Income Growth Rates AUPH's Ps Price to Sales ratio AUPH's Sales per Employee AUPH's Asset Turnover Ratio
AUPH's Net Margin AUPH's Pb Price to Book ratio AUPH's Financial Strength Ratios AUPH's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Indivior Pharmaceuticals Inc   1.88 $ 208.000  Millions$ 111  Millions
Tenet Healthcare Corp  1.88 $ 642.000  Millions$ 342  Millions
Trisalus Life Sciences Inc   1.86 $ 7.291  Millions$ 4  Millions
Elutia Inc   1.84 $ 3.772  Millions$ 2  Millions
Amgen Inc   1.81 $ 11,319.000  Millions$ 6,255  Millions
Haemonetics Corporation  1.80 $ 558.423  Millions$ 310  Millions
Orthofix Medical Inc   1.78 $ 244.423  Millions$ 137  Millions
Iradimed Corporation  1.78 $ 21.878  Millions$ 12  Millions
Harvard Bioscience Inc   1.76 $ 38.986  Millions$ 22  Millions
Ceribell Inc   1.74 $ 12.160  Millions$ 7  Millions
Axsome Therapeutics Inc   1.67 $ 58.422  Millions$ 35  Millions
Ocular Therapeutix Inc   1.66 $ 6.389  Millions$ 4  Millions
Insmed Inc  1.66 $ 237.067  Millions$ 143  Millions
Stryker Corp  1.66 $ 9,116.000  Millions$ 5,499  Millions
Bruker Corporation  1.66 $ 1,838.200  Millions$ 1,110  Millions
Bio rad Laboratories Inc   1.64 $ 1,264.000  Millions$ 769  Millions
Pfizer Inc  1.64 $ 16,940.000  Millions$ 10,322  Millions
Integra Lifesciences Holdings Corp  1.62 $ 789.329  Millions$ 486  Millions
Conmed Corporation  1.61 $ 580.951  Millions$ 361  Millions
Sanuwave Health Inc   1.54 $ 9.845  Millions$ 6  Millions
Humacyte Inc   1.53 $ 13.780  Millions$ 9  Millions
Waters Corporation  1.51 $ 1,797.864  Millions$ 1,192  Millions
Axogen inc   1.49 $ 68.923  Millions$ 46  Millions
Aurinia Pharmaceuticals Inc   1.29 $ 30.165  Millions$ 23  Millions
Hyperfine Inc   1.28 $ 8.502  Millions$ 7  Millions
Pulmonx Corporation  1.28 $ 20.450  Millions$ 16  Millions
Alphatec Holdings Inc   1.27 $ 241.341  Millions$ 189  Millions
Si bone inc   1.25 $ 46.999  Millions$ 38  Millions
Bridgebio Pharma Inc   1.24 $ 53.542  Millions$ 43  Millions
Biogen Inc   1.23 $ 2,681.800  Millions$ 2,181  Millions

Date modified: 2026-10-31T17:30:46+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.